This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
COPD, Asthma, Cystic Fibrosis, Emphysema or Small Airways Disease
and you are
between 18 and 90
years old
1
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

The goal of this study is to perform a pilot study to evaluate the utilization of oxygen as an inhaled contrast agent to image the airway spaces in normal and diseased human lungs to allow an effect size estimate to power future studies.

Provided treatments

  • Drug: Medical Grade Oxygen
Tris trial is registered with FDA with number: NCT01731015. The sponsor of the trial is Hal C Charles and it is looking for 15 volunteers for the current phase.
Official trial title:
A Pilot Study for Evaluation of Regional Lung Function in Normal Subjects and Subjects With Airway and Lung Disorders Using 1H Magnetic Resonance Imaging With Oxygen as a Contrast Agent